Houston Methodist Hospital (Site 1123), 6565 Fannin Street — Houston, Texas

Houston Methodist Hospital (Site 1123), 6565 Fannin Street is a clinical research site located in Houston, Texas, United States 77030-2703.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Houston Methodist Hospital (Site 1123), 6565 Fannin Street has participated in 1 clinical trials.

Therapeutic areas: Coronavirus, Covid19.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Houston Methodist Hospital (Site 1123), 6565 Fannin Street?

Houston Methodist Hospital (Site 1123), 6565 Fannin Street has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Houston Methodist Hospital (Site 1123), 6565 Fannin Street conducted?

Houston Methodist Hospital (Site 1123), 6565 Fannin Street has 1 clinical trials on record. Their work covers Coronavirus, Covid19.

Is Houston Methodist Hospital (Site 1123), 6565 Fannin Street accredited by Crixeo Health?

Houston Methodist Hospital (Site 1123), 6565 Fannin Street has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Houston Methodist Hospital (Site 1123), 6565 Fannin Street?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.